Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9

The anticancer properties of epigallocatechin-3-gallate (EGCG) are documented in the treatment of several types of cancer; however, there is no relevant evidence for its efficacy in the treatment of renal cell carcinoma (RCC). In the present study, the therapeutic effects of EGCG in vitro were inves...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: CHEN, SHAO-JUN, YAO, XU-DONG, PENG, BO, XU, YUN-FEI, WANG, GUANG-CHUN, HUANG, JIANHUA, LIU, MIN, ZHENG, JUN-HUA
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812156/
https://ncbi.nlm.nih.gov/pubmed/27073430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados